GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Margin of Safety % (DCF FCF Based)

VRCDF (Verici Dx) Margin of Safety % (DCF FCF Based) : N/A (As of Jul. 05, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Verici Dx's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Verici Dx's Margin of Safety % (DCF FCF Based)

For the Diagnostics & Research subindustry, Verici Dx's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verici Dx's Margin of Safety % (DCF FCF Based) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Verici Dx's Margin of Safety % (DCF FCF Based) falls into.


;
;

Verici Dx Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Verici Dx's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Verici Dx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
LSE:GENI LSE:OBD LSE:GDR LSE:PRM LSE:ABDX TSE:2397 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA LH WAT DGX XPAR:BIM ILMN
Traded in Other Exchanges
VRCI:UK 63V:Germany
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Website
https://www.vericidx.com
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx Headlines

No Headlines